Psychedelics Today, an education company, will soon be launching an in-depth, 12-month training focused on psychedelic therapy and integration.
“In the current marketplace, there’s actually a gap,” the company’s director of operations and strategic growth, David Drapkin, told Fierce Healthcare. Demand for psychedelic therapy is thriving, but the field remains available primarily only to clinicians. As a result, many are giving therapy in an unregulated space.
“The criminalization hasn’t really stopped it; it’s just driven people underground, and that can lead to safety risks and concerns because nobody knows what’s going on down there,” Drapkin said. “They’re still going to work with those people.”
